.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Farmers Insurance
Express Scripts
Cipla
Medtronic
Deloitte
QuintilesIMS
Cerilliant
Johnson and Johnson

Generated: December 15, 2017

DrugPatentWatch Database Preview

Upsher-smith Labs Company Profile

« Back to Dashboard

What is the competitive landscape for UPSHER-SMITH LABS, and when can generic versions of UPSHER-SMITH LABS drugs launch?

UPSHER-SMITH LABS has sixty-eight approved drugs.

There are ten US patents protecting UPSHER-SMITH LABS drugs on UPSHER-SMITH LABS drugs in the past three years.

There are twenty-one patent family members on UPSHER-SMITH LABS drugs in nine countries and thirty-six supplementary protection certificates in eight countries.

Summary for Upsher-smith Labs

International Patents:21
US Patents:10
Tradenames:46
Ingredients:41
NDAs:68
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Upsher-smith LabsPREVALITEcholestyraminePOWDER;ORAL073263-002Oct 30, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Upsher-smith LabsVOGELXOtestosteroneGEL;TRANSDERMAL204399-002Jun 4, 2014AB2RXNoNo► Subscribe► Subscribe► SubscribeY► Subscribe
Upsher-smith LabsSOTALOL HYDROCHLORIDEsotalol hydrochlorideTABLET;ORAL075366-004May 1, 2000AB1RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Upsher-smith LabsHYDRALAZINE HYDROCHLORIDEhydralazine hydrochlorideTABLET;ORAL083561-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Upsher-smith LabsFOSINOPRIL SODIUMfosinopril sodiumTABLET;ORAL076483-002Apr 23, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Upsher-smith LabsFOSINOPRIL SODIUMfosinopril sodiumTABLET;ORAL076483-001Apr 23, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Upsher-smith LabsPROPRANOLOL HYDROCHLORIDEpropranolol hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL078311-004Mar 6, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Upsher-smith LabsVOGELXOtestosteroneGEL, METERED;TRANSDERMAL204399-003Jun 4, 2014BXRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Upsher-smith LabsQUDEXY XRtopiramateCAPSULE, EXTENDED RELEASE;ORAL205122-001Mar 11, 2014RXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Upsher-smith LabsDIVALPROEX SODIUMdivalproex sodiumTABLET, DELAYED RELEASE;ORAL078182-003Jul 29, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for UPSHER-SMITH LABS drugs

Drugname Dosage Strength Tradename Submissiondate
topiramateExtended-release Capsules25 mg, 50 mg, 100 mg, 150 mg, and 200 mgQUDEXY XR12/24/2015
calcitonin-salmon (recombinant)Nasal Spray200 IU/sprayFORTICAL3/29/2006

International Patent Family for Upsher-smith Labs Drugs

Country Document Number Estimated Expiration
Israel241053► Subscribe
South Korea20150132838► Subscribe
Israel246134► Subscribe
European Patent Office2968177► Subscribe
World Intellectual Property Organization (WIPO)2015089289► Subscribe
Australia3660401► Subscribe
Singapore11201604788U► Subscribe
Australia2014362275► Subscribe
Hong Kong1223852► Subscribe
South Korea20160124930► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Upsher-smith Labs Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0443983/03Switzerland► SubscribePRODUCT NAME: VALSARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE; REGISTRATION NUMBER/DATE: SWISSMEDIC 59407 16.09.2009
00478Netherlands► SubscribePRODUCT NAME: TELMISARTAN, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, EN AMLODIPINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER AMLODIPINEBESILAAT; REGISTRATION NO/DATE: EU/1/10/648/001-028 20101007
00625Netherlands► SubscribePRODUCT NAME: COMBINATIE BEVATTENDE ALISKIREN, OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, EN AMLODIPINE, OF EEN FARMACEUATISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/11/686/001-056 20110414
C0012Belgium► SubscribePRODUCT NAME: AZELASTINE HYDROCHLORIDE; NAT. REGISTRATION NO/DATE: 31 IS 113 F 13 19981021; FIRST REGISTRATION: GB PL 08336/0083 19980218
C0048France► SubscribePRODUCT NAME: AMLODIPINE OU UN DE SES SELS D?ADDITION D?ACIDES PHARMACAUTIQUEMENT ACCEPTABLES/ ATORVASTATINE OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE IN FRANCE: NL 29929 DU 20050707; REGISTRATION NO/DATE AT EEC: NL 29929 DU 20050707
50009Netherlands► SubscribePRODUCT NAME: LOSARTAN, DESGEWENST IN DE VORM VAN EEN AANVAARDBAAR ZOUT, IN HET BIJZONDER HET KALIUMZOUT; NAT. REGISTRATION NO/DATE: RVG 17617 19950314; FIRST REGISTRATION: SE 12209 19940902
C/GB95/028United Kingdom► SubscribePRODUCT NAME: TOPIRAMATE; REGISTERED: UK 0242/0301 19950718
315Luxembourg► SubscribePRODUCT NAME: COMBINAISON COMPRENANT ALISKIREN,OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLE,ET AMLODIPINE,OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLE
2011 00026Denmark► SubscribePRODUCT NAME: A COMBINATION OF OLMESARTAN MEDOXOMIL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE; NAT. REG. NO/DATE: 46260-46269 (DK) 20110323; FIRST REG. NO/DATE: DE 79810.00.00 20101216
00740Netherlands► SubscribePRODUCT NAME: AZELASTINE OF EEN; NAT. REGISTRATION NO/DATE: RVG114215 20141125; FIRST REGISTRATION: 2011/07125-REG 20130215
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Deloitte
AstraZeneca
Accenture
Fish and Richardson
Harvard Business School
Farmers Insurance
Healthtrust
Moodys
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot